Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 62 | −1 |
| Shares | 18.0M | 200 | 17.7M | −255.4K (−1.4%) |
| Value | $131.8M | $1.46K | $105.1M | −$26.7M (−20.3%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wellington Management Group LLP | 102,385 | $606.1K | 0.00% |
| Two Sigma Investments, LP | 25,089 | $148.5K | 0.00% |
| Goldman Sachs Group Inc | 19,555 | $115.8K | 0.00% |
| Mariner, LLC | 17,486 | $103.5K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 11,500 | $68.0K | 0.00% |
| Old Point Trust & Financial Services N A | 500 | $2.96K | 0.00% |
| Farther Finance Advisors, LLC | 22 | $130 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 4 | $23 | 0.00% |
| CWM, LLC | 3 | $0 | 0.00% |
Sold out (10)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Balyasny Asset Management LLC | 65,305 | $478.0K |
| Mirae Asset Global Investments Co., Ltd. | 47,963 | $351.1K |
| Gsa Capital Partners LLP | 38,546 | $282.0K |
| LPL Financial LLC | 34,136 | $249.9K |
| Susquehanna International Group, LLP | 33,731 | $246.9K |
| AQR Capital Management LLC | 22,358 | $163.7K |
| American Century Companies Inc | 15,701 | $114.9K |
| Jane Street Group, LLC | 10,226 | $74.9K |
| Two Sigma Securities, LLC | 10,042 | $73.5K |
| Cutler Group LP | 100 | $0 |
Not filed for Q1 2024 yet (1)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Coppell Advisory Solutions LLC | 200 | $1.46K |